Home » News » CROs/Service Providers » Proteus and Otsuka to develop novel digital health products

Proteus and Otsuka to develop novel digital health products

Friday, July 6, 2012

Proteus Digital Health, developer of wearable and ingestible sensor technology, and Otsuka Pharmaceutical, a global healthcare company based in Japan, have entered into an exclusive worldwide license and collaboration agreement to develop and commercialize a new category of medicines.

These new medicines will be based on Otsuka’s pharmaceutical products and Proteus’s digital health feedback system incorporating Proteus’s novel sensor-based technologies. The duo will develop commercial products in two defined therapeutic areas of high unmet medical need. Otsuka has also been granted a non-exclusive license to utilize Proteus technology in its clinical research and development activities.

Financial terms of the agreement were not disclosed.

Related Posts